Histogen Inc.
NASDAQ: HSTO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Susan A. Knudson
- Employees
- 7
- Headquarters
- San Diego, United States
- IPO year
- 2013
- Market cap
- $85.4K
- Website
- https://www.histogen.com
Loading HSTO…
Loading profile data…Frequently asked questions about HSTO
What does Histogen Inc. (HSTO) do?
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular c...
Where does HSTO trade?
Histogen Inc. (HSTO) trades on the NASDAQ Capital Market.
What sector is HSTO in?
Histogen Inc. (HSTO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Histogen Inc.?
Susan A. Knudson is the chief executive officer of Histogen Inc. (HSTO).
Where is Histogen Inc. headquartered?
Histogen Inc. is headquartered in United States.
Does HSTO pay a dividend?
Histogen Inc. (HSTO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HSTO go public?
Histogen Inc. (HSTO) completed its initial public offering in 2013.